Literature DB >> 17420925

The incidence of motor nueron disease in Scotland.

Raeburn B Forbes1, Shuna Colville, John Parratt, Robert J Swingler.   

Abstract

Between 1989 and 1998, 1226 cases of ALS/MND were identified in Scotland, with mean age of onset 65.2 (SD 11.9) years for men and 67.2 (SD 11.0) for women. Annual standardized incidence was 2.40 per 100,000 (95% CI 2.22-2.58). Using capture recapture methods we confirm a high level of case ascertainment for each year of study. Incidence and ascertainment of ALS has remained stable in a large population over a prolonged period of time. Large population-based databases can be used to test aetiological hypotheses.

Entities:  

Mesh：

Year:  2007        PMID： 17420925     DOI： 10.1007/s00415-006-0454-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  8 in total

1.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 2.  Capture-recapture methods in epidemiology: methods and limitations.

Authors:  E B Hook; R R Regal
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

3.  A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis.

Authors:  C Hayward; R J Swingler; S A Simpson; D J Brock
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  Incidence of ALS in Italy: evidence for a uniform frequency in Western countries.

Authors: 
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

5.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

6.  Incidence of amyotrophic lateral sclerosis in three counties in western Washington state.

Authors:  V McGuire; W T Longstreth; T D Koepsell; G van Belle
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

7.  The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian Federation.

Authors:  P M Andersen; V A Spitsyn; S V Makarov; L Nilsson; O I Kravchuk; L S Bychkovskaya; S L Marklund
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2001-06

8.  Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O Hardiman
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910
  8 in total
  26 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

2.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

3.  Changing epidemiology of motor neurone disease in Scotland.

Authors:  Danielle J Leighton; Judith Newton; Laura J Stephenson; Shuna Colville; Richard Davenport; George Gorrie; Ian Morrison; Robert Swingler; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2019-02-25       Impact factor: 4.849

4.  ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Authors:  Hiroshi Mitsumoto; Pam Factor-Litvak; Howard Andrews; Raymond R Goetz; Leslie Andrews; Judith G Rabkin; Martin McElhiney; Jeri Nieves; Regina M Santella; Jennifer Murphy; Jonathan Hupf; Jess Singleton; David Merle; Mary Kilty; Daragh Heitzman; Richard S Bedlack; Robert G Miller; Jonathan S Katz; Dallas Forshew; Richard J Barohn; Eric J Sorenson; Bjorn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Jeremy M Shefner; Jinsy A Andrews; Boguslawa A Koczon-Jaremko
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-24       Impact factor: 4.092

5.  Age-specific ALS incidence: a dose-response meta-analysis.

Authors:  Benoît Marin; Andrea Fontana; Simona Arcuti; Massimilano Copetti; Farid Boumédiene; Philippe Couratier; Ettore Beghi; Pierre Marie Preux; Giancarlo Logroscino
Journal:  Eur J Epidemiol       Date:  2018-04-23       Impact factor: 8.082

6.  Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.

Authors:  Adriano Chiò; Gabriele Mora; Cristina Moglia; Umberto Manera; Antonio Canosa; Stefania Cammarosano; Antonio Ilardi; Davide Bertuzzo; Enrica Bersano; Paolo Cugnasco; Maurizio Grassano; Fabrizio Pisano; Letizia Mazzini; Andrea Calvo
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

7.  Updated Prevalence and Demographic Characteristics for ALS Cases in Texas, 2009-2011.

Authors:  Lindsay Rechtman; Laurie Wagner; Wendy Kaye; John Villanacci
Journal:  South Med J       Date:  2015-08       Impact factor: 0.954

8.  Incidence of amyotrophic lateral sclerosis in Europe.

Authors:  Giancarlo Logroscino; Bryan J Traynor; Orla Hardiman; Adriano Chiò; Douglas Mitchell; Robert J Swingler; Andrea Millul; Emma Benn; Ettore Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

Review 9.  Current pathways for epidemiological research in amyotrophic lateral sclerosis.

Authors:  Pam Factor-Litvak; Ammar Al-Chalabi; Alberto Ascherio; Walter Bradley; Adriano Chío; Ralph Garruto; Orla Hardiman; Freya Kamel; Edward Kasarskis; Ann McKee; Imaharu Nakano; Lorene M Nelson; Andrew Eisen
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 10.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.